Global Prosperity Wonkcast

On December 15th the Millennium Challenge Corporation (MCC), an innovative U.S. aid agency, is set to announce which countries will receive its unique development assistance. Casey Dunning, policy analyst at CGD and my guest on this week’s Wonkcast, provides insight and recommendations on how these countries will (and should) be selected. I catch Casey shortly after her return from Honduras, where she saw firsthand the positive impacts of an MCC compact on rural development and highway construction.

Ghana’s recent recalculation of its GDP led to an overnight $500 per capita jump, putting in motion unexpectedly rapid graduation from the International Development Association (IDA) and ultimately a new relationship with the World Bank. In this week’s Wonkcast, I speak with Todd Moss, vice president for programs and senior fellow at CGD, about his recent trip to the newly categorized lower-middle income country, the implications of IDA graduation, and a sudden influx of oil wealth.

My guest this week is Mead Over, one of the world’s leading experts on the global response to the HIV/AIDS pandemic. We discuss his new book, Achieving an Aids Transition: Preventing Infections to Sustain Treatment. The key idea is simple but powerful. Mead argues that, instead of reaching vainly for the unsustainable goal of offering treatment to everyone in the developing world who needs it, donor policy should aim to sustain current treatment levels while reducing the number of new infections below the number of AIDS deaths, so that the total number of people with HIV/AIDS declines.

“The escalating number of people infected with HIV/AIDS is far outpacing available funding for treatment, especially in Africa,” Mead tells me. “Only by holding deaths down and preventing new infections will the total number of people with HIV decline and an AIDS transition be reached.”

In this Wonkcast, originally posted on July 2010, Tom Bollyky explains the problems that motivated him in establishing CGD’s Clinical Trials and Regulatory Pathways Working Group. The group’s final report, Safer, Faster, Cheaper: Improving Clinical Trials and Regulatory Pathways to Fight Neglected Diseases, will be released on Monday, October 31, with keynote remarks by Margaret Hamburg, Commissioner of the U.S. Food and Drug Administration. Listen to the Wonkcast to understand the problems and get a sneak preview on the proposed solutions. RSVP here to attend the event.